Angiotensin II type 2 receptor blockade increases bone mass. - Wikidata - wikimedia - TriplyDB

Angiotensin II type 2 receptor blockade increases bone mass.

Angiotensin II type 2 receptor blockade increases bone mass.

http://www.wikidata.org/entity/Q37344123

about

Potential of RAS inhibition to improve metabolic bone disorders Functional Local Renin-Angiotensin System in Human and Rat Periodontal Tissue Partial agonist, telmisartan, maintains PPARγ serine 112 phosphorylation, and does not affect osteoblast differentiation and bone mass Locally administrated perindopril improves healing in an ovariectomized rat tibial osteotomy model Angiotensin (1-7) ameliorates the structural and biochemical alterations of ovariectomy-induced osteoporosis in rats via activation of ACE-2/Mas receptor axis.Effects of 1,25-dihydroxyvitamin D3 on the local bone renin-angiotensin system in a murine model of glucocorticoid-induced osteoporosis.ACE inhibitor use was associated with lower serum dehydroepiandrosterone concentrations in older men Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation - role of a local renin-angiotensin system.Inflammation and vitamin D: the infection connection Genetic determinants of osteoporosis: common bases to cardiovascular diseases?Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome Type XII collagen regulates osteoblast polarity and communication during bone formation Systemic treatment with telmisartan improves femur fracture healing in mice Reciprocal roles of angiotensin II and Angiotensin II Receptors Blockade (ARB) in regulating Cbfa1/RANKL via cAMP signaling pathway: possible mechanism for hypertension-related osteoporosis and antagonistic effect of ARB on hypertension-related oste Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton.Molecular genetic studies of gene identification for osteoporosis: the 2009 update Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men?Non-canonical signalling and roles of the vasoactive peptides angiotensins and kinins.Piperazine derivatives for therapeutic use: a patent review (2010-present).Angiotensin receptor I stimulates osteoprogenitor proliferation through TGFβ-mediated signaling.ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men.Role of reactive oxygen species in angiotensin II: induced receptor activator of nuclear factor-κB ligand expression in mouse osteoblastic cells.Mechanical induction of interleukin-11 regulates osteoblastic/cementoblastic differentiation of human periodontal ligament stem/progenitor cells.Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist in a rat model of prostate cancer-induced bone pain.Collagens VI and XII form complexes mediating osteoblast interactions during osteogenesis.Continuous infusion of angiotensin II modulates hypertrophic differentiation and apoptosis of chondrocytes in cartilage formation in a fracture model mouse.Protective effects of the angiotensin type 1 receptor antagonist losartan in infection-induced and arthritis-associated alveolar bone loss.Aliskiren has chondroprotective efficacy in a rat model of osteoarthritis through suppression of the local renin-angiotensin system.Physiological function of the angiotensin AT1a receptor in bone remodeling.Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes.Effect of angiotensin II receptor blocker, olmesartan, on turnover of bone metabolism in bedridden elderly hypertensive women with disuse syndrome.The roles of angiotensin II in stretched periodontal ligament cells.Effects of angiotensin II type 1 receptor blocker on bones in mice with type 1 diabetes induced by streptozotocin.Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies.Association between renin-angiotensin-aldosterone system blockade and future osteoporotic fracture risk in hypertensive population: A population-based cohort study in Taiwan.Involvement of the skeletal renin-angiotensin system in age-related osteoporosis of ageing mice.Long-term use of angiotensin-converting enzyme inhibitors protects against bone loss in African-American elderly men.PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization.ST1926 Attenuates Steroid-Induced Osteoporosis in Rats by Inhibiting Inflammation Response.Effects of losartan treatment on the physicochemical properties of diabetic rat bone.

P2860

Q26866515-AC9714BD-554F-4562-8F50-556C84BF7759 Q27301201-9BCD21A2-96D3-4CA5-A464-DA759690251B Q27334866-94FDA200-305A-43C0-85F4-9D12C7841690 Q31051550-36EA6B1C-3C11-4375-AC90-5BC2AD3E6689 Q33720171-FEEBA03B-33E4-4ABE-87E8-A85A0AAB5105 Q33744694-027173BC-F88D-46CB-9021-2DCD912D8B72 Q33905626-0B81E253-F9E4-4223-968D-8CC1154F5E0E Q34078763-A72CC027-56FE-4163-901D-8ACE44F67F19 Q34161811-3AA39D6B-8501-4A08-9A49-F230E3128CA2 Q34170688-16D9E879-D9D4-4FFF-B320-2A74C7DFBE46 Q34341127-EA24F60E-23BA-4572-9A0A-2AF67E1780B6 Q35047456-4E7F5EEA-DFC1-4F8D-B0ED-6BC5C5995CFB Q35124201-BA86B709-4F36-4A51-95A8-43F7D83665EF Q35162095-7F04C00F-5B02-4E1B-A2D4-90E48C53414E Q35588952-0C9AF02B-71B7-444B-AA6A-7B91B5D1B5F6 Q36003387-A1591EBC-F95E-4870-94C5-0F1DD70939E0 Q37168592-2E43A573-EC59-4D31-AED1-7E968EDD202E Q38190099-97785690-A3C0-4963-9FC6-7401FD566569 Q38833869-F9DD687A-3C09-4D68-A558-74A330BD0127 Q38923502-7BD733DD-5735-457E-A662-7ED3FF2CB0A7 Q38970231-B504FC18-61A2-4BB9-A533-895E4C80630E Q38971560-61A7DC89-0DC9-46CD-9611-BD0E2A0C9A8F Q38982739-E7ED1032-C8DE-4A12-908A-1DDA8AE90BE4 Q39033886-12C42267-6E8C-4F67-BACB-D8CF2FCC485F Q40121511-53AD8D9D-391F-4C4C-A62F-6528B53C6606 Q41398780-EC285B6C-7F50-4A26-BA32-0D7111D019DE Q41441856-60E9B068-9315-4E6D-9E96-D93554A312C0 Q42679493-1A1D1534-A109-4C6C-BDD2-D1A44C2941BD Q44829000-23C63B63-584D-40CD-ABFA-ED94EADD993D Q45859011-8364F597-262A-4B3B-9C66-AAA23C5E6F82 Q45869847-BAC314A4-9697-4353-8921-97A7513E4038 Q46481285-10F44A29-6EEF-47EF-8E41-DB3EACE0D936 Q46506399-6AA449AE-EC40-4643-8E25-1E181B0DB79E Q47124228-5335F1A5-F9E5-4A54-A9AF-A77FAEE9C422 Q47134620-4FC82351-4494-4C06-A92A-C835572ABE44 Q47395118-C57A231E-9940-40D0-9440-F8A294CAAF4A Q47696199-695C0A5A-62F6-4647-B091-A337F5E33A17 Q50510999-6423B43E-694E-4058-BA3D-E1A7573C890B Q51285465-0F7458A9-5697-4602-87AD-6D13B745843A Q51398203-F64AE484-7915-4A1F-9715-B3439EC2E22E

P2860

Angiotensin II type 2 receptor blockade increases bone mass.

http://www.wikidata.org/entity/Q37344123

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Angiotensin II type 2 receptor blockade increases bone mass.

@en

Angiotensin II type 2 receptor blockade increases bone mass.

@nl

type

label

Angiotensin II type 2 receptor blockade increases bone mass.

@en

Angiotensin II type 2 receptor blockade increases bone mass.

@nl

prefLabel

Angiotensin II type 2 receptor blockade increases bone mass.

@en

Angiotensin II type 2 receptor blockade increases bone mass.

@nl

P1433

Q37344123-298677C8-5B06-491E-9F7D-0178DE897B83

P1476

Q37344123-C20C0829-69FB-4A0D-AB32-7A700E0A2245

P2093

Q37344123-1BAC5CDD-D909-47B3-ACF0-9083C91F780F

Q37344123-711158B6-C640-428A-9F54-128E5DF82439

Q37344123-72A3584B-0E2F-4074-888B-743A6396F1A3

Q37344123-80E514EE-E382-4A8A-8520-6DE4ADB8CD11

Q37344123-827FBD06-9176-4C8C-B983-FED9E7CDA89B

Q37344123-8F80F8C7-B255-464C-8B36-175826794583

Q37344123-B7C950C9-7F52-496D-9FBF-84A02840BC6E

Q37344123-C9301337-01E9-4341-9122-E01D76E12C0D

Q37344123-D305F9F7-0D64-444B-BD24-67E8F0517348

P2860

Q37344123-149AEE73-8647-4075-8967-B93BE102EBB8

Q37344123-1586F365-D5C9-457C-BF04-16382D84B47B

Q37344123-18EBAD77-5645-44B0-A778-39148D0657F0

Q37344123-23CC4572-C3C2-4711-9F83-A41F56A40F5D

Q37344123-329DB6A4-9999-447B-BA37-ABEF55F63956

Q37344123-3D127F4D-8653-4D63-A363-BE369DE18654

Q37344123-56F418D9-C1F0-41A6-9128-976CC7B5392C

Q37344123-59E24930-D35C-4356-8D7C-7C77B591890C

Q37344123-5D88C11F-78F1-4CA9-AC99-8C026453ABEF

Q37344123-65D40D72-A3EC-4E75-A421-8D421AABCB8A

P304

Q37344123-85366C07-5BD5-4951-BA00-B69349B48CCB

P31

Q37344123-BEF4CBA0-E77B-4884-A9E7-F9FDC229DB96

P356

Q37344123-014C246B-1176-4AD4-99ED-B65BE7DEB7BC

P407

Q37344123-4E1C4ED8-3E07-4DFB-B28C-CE4AAE934D31

P433

Q37344123-5F90180D-328D-4571-8CDF-3394CCD62AB7

P478

Q37344123-BE80A1F0-701A-4C2C-8A52-415BC3C8B9A5

P577

Q37344123-317FDDC3-C270-46AD-B61A-133A9402DD76

P698

Q37344123-38E2FD09-47FE-40C6-B492-01EF40823679

P932

Q37344123-3CD67588-0272-4425-9DE9-53052EFF527E

P356

P1433

Journal of Biological Chemistry

P1476

Angiotensin II type 2 receptor blockade increases bone mass.

@en

P2093

Aya Kawamata

http://www.w3.org/2001/XMLSchema#string

Fumitaka Mizoguchi

http://www.w3.org/2001/XMLSchema#string

Kazuhisa Nakashima

http://www.w3.org/2001/XMLSchema#string

Masaki Noda

http://www.w3.org/2001/XMLSchema#string

Tadashi Inagami

http://www.w3.org/2001/XMLSchema#string

Tadayoshi Hayata

http://www.w3.org/2001/XMLSchema#string

Testuya Nakamoto

http://www.w3.org/2001/XMLSchema#string

Yayoi Izu

http://www.w3.org/2001/XMLSchema#string

Yoichi Ezura

http://www.w3.org/2001/XMLSchema#string

P2860

A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy

Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor

Leptin regulation of bone resorption by the sympathetic nervous system and CART

Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment

Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization.

Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis

Leptin regulates bone formation via the sympathetic nervous system.

Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow.

Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system.

Local production of angiotensin II in the subfornical organ causes elevated drinking

P304

4857-4864

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M807610200

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

284

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19004830

http://www.w3.org/2001/XMLSchema#string

P932

2742875

http://www.w3.org/2001/XMLSchema#string